Innovation des technologies diagnostiques moléculaires pour la clinique

Tuesday, 21 April, 2015 - 08:30 to 10:00

Chair

Tania Bubela

University of Alberta

Pre-Discussion Presentation

Katherine Bonter

Director of Commercialization Research, Personalized Cellular Immunotherapy Project, Hôpital Maisonneuve Rosemont

Panelists

Carmela De Luca

Partner, Bereskin & Parr LLP

Chris Wagner

President and Chief Executive Officer, Contextual Genomics, Inc.

Mel Krajden

Medical Director, Public Health Serology, Provinical Health Services Laboratories, BC Centre for Disease Control

Brad Popovich

Chief Scientific Officer, Genome British Columbia